Hilliard Lyons upgraded its stock rating for Microsoft Corporation (NASDAQ MSFT) to long-term Buy with a price target of $52 per share due to the improving operating performance of the company. Hilliard Lyons technology analyst, Stephen Turner said that a strong cloud adoption and constructive cost containment prompted them to upgrade their rating for Microsoft…
Overall, mortgage interest rates remained unchanged today, although at some lenders rates slightly improved following the improvements in bond markets during the day. At Charlotte-based major mortgage provider, Bank of America Corporation (NYSE:BAC), interest rates haven’t seen any changes today, according to our observations. Annual percentage rates, on the other hand, look mixed this Tuesday….
Shares of AK Steel Holding (NYSE:AKS) have been given a consensus recommendation of “Hold” by the ten ratings firms that are covering the company. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating on the company. AK Steel Holding Corporation…
The U.S. drug maker offered Idenix Pharmaceuticals Inc. (NASDAQ:IDIX) shareholders $24.50 a share, or $3.85 billion, for the developer of hepatitis C drugs. That’s almost quadruple the stock’s average unaffected price over the previous 20 days, the highest premium on record for any health care deal of at least $100 million, according to data compiled…
As part of its streamlining program, BlackBerry Limited (NASDAQ:BBRY) (TSE:BB) sold its U.S. headquarters in Irving, Texas to Canadian real estate company, Brookfield Property Group. However, financial details of the deal have not been revealed. BlackBerry Ltd (NASDAQ:BBRY) stock performance was -1.84% in last session and finished the day at $9.05. Traded volume was 20.11…
The Rosen Law Firm, P.A. reminds purchasers of Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) between March 15, 2012 and January 9, 2014, inclusive (the “Class Period”) of the important Mach 17, 2014 lead plaintiff deadline in the class action seeking remedies under the federal securities laws. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) stock performance was -5.40% in last session…
Tech Analysis & Market News